Home » Topics » BioWorld Science

BioWorld Science
RSS

Novavax reports COVID-19 vaccine data against SARS-CoV-2 Beta variant

June 14, 2021

Preliminary phase I results for NEXI-002 in R/R MM reported at EHA

June 14, 2021

Phase Ia/b data for APTO-253 in patients with relapsed/refractory AML or high-risk MDS

June 14, 2021

U.K.'s MHRA clears initiation of phase II trial of COVID-DROPS

June 14, 2021

Ossianix patents TfR1-targeting antibodies for neurodegeneration

June 14, 2021

Preliminary first-in-human data presented for BDC-1001 in HER2-expressing solid tumors

June 14, 2021

Albiero Pharma synthesizes new ASBT and/or NTCP inhibitors

June 14, 2021

Shijiazhuang Yiling Pharmaceutical identifies HIPK2 inhibitors

June 14, 2021

Sunshine Lake Pharma presents new antimigraine drugs

June 14, 2021

Shanghai Ennova Biopharmaceutical patents new TRK inhibitors

June 14, 2021

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...